Reference lab services, vexas syndrome IDIQ
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36C26125D0009
- Awardee
-
Diacarta, Inc. UEI LY4NEL8B8FK9
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 2 $38,208 obligated
Award facts
- Opportunity
-
- Q301--Reference Lab Services for VASFHCS - UBA1 VEXAS Syndrome Pre-Solicitation · 36C26124Q0750 · Posted Jun 26, 2024
- Combined order value
- $38,208 Current and potential, with all options
- Last date to order 41% complete
- IDV ceiling 19% used
- $200,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
Veterans Integrated Service Network 21 awarded a single-award indefinite-delivery contract to Diacarta, Inc. with a ceiling of $200,000 on October 1, 2024, for reference laboratory services related to VEXAS syndrome diagnosis. No set-aside was used.
Performance occurs in Pleasanton, California. The contract supports specimen pickup, testing, reporting, and consultation services for somatic mutations of the UBA1 gene, with the contractor required to maintain CLIA certification and professional liability insurance and meet specified turnaround time requirements.
The period of performance runs from October 1, 2024, through September 30, 2029. VISN 21 issued delivery orders under this IDIQ for fiscal years 2025 and 2026, each with a ceiling of $19,104 and firm fixed-price pricing. The FY25 task order was awarded on October 1, 2024, with performance ending September 30, 2025; the FY26 task order was awarded on October 1, 2025, with performance ending September 30, 2026. Both orders are performed at the Pleasanton facility.
The underlying market research, conducted by the San Francisco VA Health Care System in June 2024, identified the need for specialized laboratory testing capabilities to support VEXAS syndrome diagnosis across the Veterans Affairs system. The contract reflects an Executive Order 14398 requirement to establish this reference laboratory capacity.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Reference lab services, vexas syndrome FY26 task order | Veterans Integrated Service Network 21 (VHA) | $19,104 | |
| Vexas reference lab services FY25 | Veterans Integrated Service Network 21 (VHA) | $19,104 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36C26125D0009?
36C26125D0009 was awarded to Diacarta, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C26125D0009 worth?
Orders under 36C26125D0009 have obligated $38,208. 36C26125D0009's own ceiling is $200,000.
How many orders have been placed under contract 36C26125D0009?
2 orders have been placed under 36C26125D0009, the latest on October 1, 2025.
Who can order from contract 36C26125D0009?
36C26125D0009 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 36C26125D0009 competed?
The extent of competition for 36C26125D0009 was competed under sap. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV